Opiant Pharmaceuticals (OPNT) Income Statement

Click line-items for a historical chart and %

Product	22M
Product updates, technical support and services	17.95M
Professional services	7.11M
Total revenue	47.06M
Product	3.79M
Product updates, technical support and services	1.67M
Professional services	4.79M
Amortization of acquired technology and customer relationships	800K
Total cost of revenue	11.05M
Gross profit	36.01M
Research and development	10.99M
Sales and marketing	15.24M
General and administrative	3.7M
Total operating expenses	29.92M
Income from operations	6.1M
Interest and other expense, net	34K
Income before provision for income taxes	6.13M
Provision for income taxes	2.28M
Net income	3.86M
Basic net income per common share	0.17
Diluted net income per common share	0.17
Basic weighted average common shares outstanding	22.64M
Diluted weighted average common shares outstanding	22.92M

Entities mentioned with OPNT

View All Entities